Notice of the Device Audit Center of the State Food and Drug Administration (No. 39, 2022)

Date of issue:

2022-11-03

Views:

In order to further standardize the management of additive manufacturing of intervertebral fusion cages, the National Drug Administration's Instrument Audit Center has organized and formulated the Guiding Principles for Registration and Review of Additive Manufacturing of Intervertebral Fusion Cages, which is hereby promulgated.




It is hereby notified.


State Drug Administration

Medical Device Technical Evaluation Center

November 3, 2022


Recommend

Notice on Organizing the Work of Launching the Innovation Task of Biomedical Materials
All provinces, autonomous regi...
Wuhan Asia Biological was approved as a medical device for artificial bone repair
On November 14, the State Food...
Notice of the Device Audit Center of the State Food and Drug Administration (No. 39, 2022)
In order to further standardiz...
Q1-1 Biomaterials for bone regeneration
Inanimate biomaterials can ind...